Ninety One (UK)
MRNA icon

Ninety One (UK)’s Moderna MRNA Stock Holding History

Ninety One (UK)’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-68,283
Closed -$4.56M – 204
2024
Q3 		$4.56M Sell
68,283
-23,594
-26% -$2.17M 0.01% 168
2024
Q2 		$10.9M Buy
+91,877
New +$11.6M 0.03% 150
2022
Q2 		– Sell
-57,757
Closed -$9.95M – 199
2022
Q1 		$9.95M Buy
57,757
+23,344
+68% +$3.93M 0.03% 168
2021
Q4 		$8.74M Sell
34,413
-9,623
-22% -$2.81M 0.02% 179
2021
Q3 		$16.9M Sell
44,036
-30,089
-41% -$11.1M 0.04% 156
2021
Q2 		$17.4M Buy
+74,125
New +$13.2M 0.05% 163

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Ninety One (UK)'s MRNA Position: Q4 2024 in Review

Ninety One (UK) sold out of Moderna (MRNA) in Q4 2024, closing a stake of 68,283 shares — an estimated $4.56M sold.

Ninety One (UK) first reported a position in MRNA in Q2 2021 and held it in 6 quarters. The position peaked at $17.4M in Q2 2021. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Ninety One (UK) reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • Ninety One (UK) sold 68,283 Moderna shares in Q4 2024, an estimated $4.56M.
  • Ninety One (UK) first reported a position in Moderna in Q2 2021 and held it in 6 quarters.
  • Ninety One (UK)'s Moderna position peaked at $17.4M in Q2 2021.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Ninety One (UK)'s 13F filing for Q4 2024, filed 27 Jan 2025.